Colorectal Cancer: Current and Future Therapeutic Approaches and Related Technologies Addressing Multidrug Strategies Against Multiple Level Resistance Mechanisms
International Journal of Molecular Sciences · 04.02.2025 · 26 (3) · 1313
DOI: 10.3390/ijms26031313 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.02.2025. Verfasst von Marianna Puzzo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical, Biomolecular and Genetic Analyses Unit, Annunziata Hospital, 87100 Cosenza, Italy. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Drug Resistance, Neoplasm, Drug Resistance, Multiple. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Plan for NRRP Complementary Investments.
Abstract (Originalsprache)
Colorectal cancer (CRC) is the third most common cancer and is associated with a poor prognosis. The mutation profile and related involved pathways of CRC have been, in broad terms, analyzed. The main current therapeutic approaches have been comprehensively reviewed here, and future possible therapeu-tic options and related technologies have been perspectively presented. The complex scenario represented by the multiple-level resistance mechanism in the epidermal growth factor receptor (EGFR) pathway, including mutations in KRAS, NRAS, and BRAF V600E, is discussed. Examples of engineered therapeutic approaches from the literature along with a drug combination tested in clinical trials are discussed. The encouraging results observed with the latter combination (the BEACON clinical trial), totally free from chemotherapy, prompted the authors to imagine a future possible nanotechnology-assisted therapeutic approach for bypassing multiple-level resistance mechanisms, hopefully allowing, in principle, a complete biological cancer remission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical, Biomolecular and Genetic Analyses Unit, Annunziata Hospital, 87100 Cosenza, Italy.
- Department of Pharmacy, Health and Nutritional Sciences University of Calabria, Via P. Bucci, 87036 Arcavacata di Rende, Italy.
- NanoSiliCal Devices s.r.l., University of Calabria, 87036 Arcavacata di Rende, Italy.
- Department of Environmental Engineering, University of Calabria, Via P. Bucci, 87036 Arcavacata di Rende, Italy.
ORCID-Profile: Marianna Puzzo, Catia Morelli, Antonella Leggio
Förderung
- National Plan for NRRP Complementary Investments
Zitieren
APA
Puzzo, M., De Santo, M., Morelli, C., Leggio, A., Catalano, S., & Pasqua, L. (2025). Colorectal Cancer: Current and Future Therapeutic Approaches and Related Technologies Addressing Multidrug Strategies Against Multiple Level Resistance Mechanisms. International Journal of Molecular Sciences, 26(3), 1313. https://doi.org/10.3390/ijms26031313
Vancouver
Puzzo M, De Santo M, Morelli C, Leggio A, Catalano S, Pasqua L. Colorectal Cancer: Current and Future Therapeutic Approaches and Related Technologies Addressing Multidrug Strategies Against Multiple Level Resistance Mechanisms. International Journal of Molecular Sciences. 2025;26(3):1313. doi:10.3390/ijms26031313
BibTeX
@article{Puzzo2025,
author = {Puzzo, Marianna and De Santo, Marzia and Morelli, Catia and Leggio, Antonella and Catalano, Stefania and Pasqua, Luigi},
title = {Colorectal Cancer: Current and Future Therapeutic Approaches and Related Technologies Addressing Multidrug Strategies Against Multiple Level Resistance Mechanisms},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {3},
pages = {1313},
doi = {10.3390/ijms26031313}
}
EUVIMED